Morgan Stanley’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Morgan Stanley’s Portfolio CRTX Stock Details CRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-130,480	Closed	-$1.24M	–	6739
2013 Q4	$1.24M	Buy	130,480 +16,715	+15%	+$158K	﹤0.01%	3752
2013 Q3	$1.07M	Buy	113,765 +31,769	+39%	+$286K	﹤0.01%	3736
2013 Q2	$655K	Buy	+81,996	New	+$691K	﹤0.01%	4061

Other funds holding CRTX

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Morgan Stanley's CRTX Position: Q1 2014 in Review

Morgan Stanley sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 130,480 shares — an estimated $1.24M sold.

Morgan Stanley first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $1.24M in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

Morgan Stanley reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
Morgan Stanley sold 130,480 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $1.24M.
Morgan Stanley first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
Morgan Stanley's CORNERSTONE THERAPEUTICS INC position peaked at $1.24M in Q4 2013.
1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Morgan Stanley's 13F filing for Q1 2014, filed 13 May 2014.